This company has been marked as potentially delisted and may not be actively trading. Akouos (AKUS) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock AKUS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period NOVARTIS AG's Net WorthMay 3, 2024 | benzinga.comJoshua Makower's Net WorthApril 5, 2024 | benzinga.comWilliam W. Backus HospitalMay 17, 2023 | health.usnews.comRectify Pharmaceuticals Appoints Sachiyo Minegishi as Chief Operating OfficerMay 16, 2023 | finance.yahoo.comAcquisition Corp Kearny Purchases 29,992,668 Shares of Akouos, Inc. (NASDAQ:AKUS) StockDecember 1, 2022 | marketbeat.comLilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic DiseasesDecember 1, 2022 | finance.yahoo.comAkouos (Nasdaq:AKUS) HeadlineTrading was temporarily halted for "AKUS" at 07:11 PM with a stated reason of "News pending."...December 1, 2022 | marketbeat.comBrokers Issue Forecasts for Akouos, Inc.'s FY2022 Earnings (NASDAQ:AKUS)November 17, 2022 | marketbeat.comAkouos Reports Third Quarter 2022 Financial Results and Provides Business HighlightsNovember 14, 2022 | finance.yahoo.comShort Interest in Akouos, Inc. (NASDAQ:AKUS) Drops By 63.4%November 11, 2022 | marketbeat.comAkouos (AKUS) Set to Announce Earnings on ThursdayAkouos (AKUS) Set to Announce Earnings on Thursday...November 9, 2022 | marketbeat.comAkouos Target of Unusually Large Options Trading (NASDAQ:AKUS)October 24, 2022 | marketbeat.comAkouos, Inc. to Post Q3 2022 Earnings of ($0.66) Per Share, William Blair Forecasts (NASDAQ:AKUS)Akouos, Inc. to Post Q3 2022 Earnings of ($0.66) Per Share, William Blair Forecasts (NASDAQ:AKUS)...October 21, 2022 | marketbeat.comAkouos stock soars 87% as Lilly nabs hearing loss gene therapy developer - Seeking AlphaOctober 19, 2022 | seekingalpha.comAKUS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Akouos, Inc. Is Fair to Shareholders - Business WireOctober 18, 2022 | businesswire.comAkouos (NASDAQ:AKUS) Lowered to Market Perform at William BlairOctober 18, 2022 | marketbeat.comCrude Oil Drops Over 2%; Akouos Shares Spike Higher - Akouos (NASDAQ:AKUS), ADS-TEC Energy (NASDAQ:ADSE) - BenzingaOctober 18, 2022 | benzinga.comEli Lilly To Pay Up To $610M For Gene Therapy Biz Akouos - Law360October 18, 2022 | law360.comEli Lilly to buy genetic medicine developer Akouos for $487 million - NasdaqOctober 18, 2022 | nasdaq.com2022-10-18 | NDAQ:AKUS | Press Release | Akouos Inc. - StockhouseOctober 18, 2022 | stockhouse.comEli Lilly to Buy Akouos for Up to $610 Million >LLY AKUS - MarketWatchOctober 18, 2022 | marketwatch.comAkouos Shares Soar on Takeover by Eli Lilly >AKUS - MarketWatchOctober 18, 2022 | marketwatch.comEli Lilly to acquire Akouos for up to about $610 million and develop gene therapies for hearing loss - MarketWatchOctober 18, 2022 | marketwatch.comEli Lilly To Buy Akouos For Up To $610 Mln - NasdaqOctober 18, 2022 | nasdaq.comEli Lilly & Co. (LLY) Acquires Akouos (AKUS) for $610M - StreetInsider.comOctober 18, 2022 | streetinsider.comAkouos, Inc. (AKUS) Upgraded to Strong Buy: Here's Why - NasdaqOctober 10, 2022 | nasdaq.comAkouos, Inc. (AKUS) Upgraded to Strong Buy: Here's WhyOctober 10, 2022 | finance.yahoo.comAKUS stock rated Bullish at William Blair on gene therapy for hearing loss (NASDAQ:AKUS) - Seeking AlphaSeptember 29, 2022 | seekingalpha.comAkouos Gains as William Blair Starts Coverage at Outperform - Marketscreener.comSeptember 29, 2022 | marketscreener.comMAkouos (NASDAQ:AKUS) Coverage Initiated at William BlairSeptember 29, 2022 | marketbeat.comArthur Tzianabos, Ph.D., June Lee, MD FACCP, and Joseph Loscalzo, MD, Ph.D. Join 5AM Ventures - Yahoo FinanceSeptember 27, 2022 | finance.yahoo.comWhy Comera Life Sciences Shares Jumped 101%; Here Are 74 Biggest Movers From Yesterday By Benzinga - Investing.com UKSeptember 14, 2022 | uk.investing.comAlcohol Justice to Participate at Alcohol Policy-19 Evidence to Action: Building a Framework for Change - Yahoo FinanceSeptember 14, 2022 | finance.yahoo.comFDA Clears Akouos' Gene Therapy Trial For Genetic Form Of Hearing LossSeptember 13, 2022 | finance.yahoo.comAkouos Receives FDA Clearance of its IND Application for AK-OTOF, a Gene Therapy Intended for the Treatment of OTOF-mediated Hearing LossSeptember 13, 2022 | finance.yahoo.comAkouos Says FDA Clears IND Application For AK-OTOF For OTOF-mediated Hearing LossSeptember 13, 2022 | markets.businessinsider.comAkouos stock rises 11% on FDA clearance to start gene therapy trial for hearing loss - Seeking AlphaSeptember 13, 2022 | seekingalpha.comForm SC 13G/A Akouos, Inc. Filed by: FEDERATED HERMES, INC. - StreetInsider.comSeptember 9, 2022 | streetinsider.comAkouos, Inc. (AKUS) Upgraded to Buy: Here's Why - NasdaqAugust 18, 2022 | nasdaq.comAkouos, Inc. (AKUS) Upgraded to Buy: Here's WhyAugust 18, 2022 | finance.yahoo.comAkouos (NASDAQ:AKUS) Issues Earnings ResultsAugust 16, 2022 | marketbeat.comThis Financial Services Stock Surged Around 116%; Here Are 86 Biggest Movers From Yesterday - BenzingaAugust 16, 2022 | benzinga.comAkouos Reports Second Quarter 2022 Financial Results and Provides Business Highlights - Yahoo FinanceAugust 16, 2022 | finance.yahoo.comAKOUOS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) - Marketscreener.comAugust 15, 2022 | marketscreener.comMAkouos: Q2 Earnings Insights - BenzingaAugust 15, 2022 | benzinga.comAkouos GAAP EPS of -$0.58 beats by $0.21 (NASDAQ:AKUS) - Seeking AlphaAugust 15, 2022 | seekingalpha.comAkouos Reports Second Quarter 2022 Financial Results and Provides Business Highlights - GlobeNewswireAugust 15, 2022 | globenewswire.comAKOUOS, INC. : Change in Directors or Principal Officers (form 8-K) - Marketscreener.comJuly 26, 2022 | marketscreener.comMGlycoEra AG Expands Board of Directors and Appoints Georges Gemayel, Ph.D., as Chair - PR NewswireJuly 12, 2022 | prnewswire.comCan You Pull Off Early Retirement, Despite the Recent Stock Market Downturn? - NasdaqJuly 7, 2022 | nasdaq.com Get Akouos News Delivered to You Automatically Sign up to receive the latest news and ratings for AKUS and its competitors with MarketBeat's FREE daily newsletter. Email Address AKUS Media Mentions By Week AKUS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AKUS News Sentiment▼0.000.99▲Average Medical News Sentiment AKUS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AKUS Articles This Week▼00▲AKUS Articles Average Week Get Akouos News Delivered to You Automatically Sign up to receive the latest news and ratings for AKUS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Calliditas Therapeutics AB (publ) News Zymeworks News Chimerix News Avid Bioservices News MBX Biosciences News Revance Therapeutics News Checkpoint Therapeutics News Aerovate Therapeutics News 2seventy bio News Acelyrin News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AKUS) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akouos, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Akouos With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
